Table 4.
Tumor markers including CEA, CA199, and CA724 in the two groups (mean ± sd, %)
| Group | CEA (ng/mL) | CA199 (ng/mL) | CA724 (ng/mL) |
|---|---|---|---|
| Exp (n=13) | |||
| Pretherapy | 23.7±15.8 | 47.2±32.5 | 22.5±14.6 |
| Posttherapy | 13.6±10.2*,** | 28.9±18.2*,** | 16.4±11.3*,** |
| Con (n=15) | |||
| Pretherapy | 22.6±14.1 | 46.8±33.6 | 24.1±15.2 |
| Posttherapy | 18.5±12.3* | 35.6±22.7* | 20.3±13.6* |
Notes:
*
P<0.05, comparisons between pretherapy and posttherapy in each group.
**
P<0.05, posttherapy comparisons between the two groups.
Abbreviations: Exp, experimental; Con, control; sd, standard deviation.